Injectable Drug Delivery Solutions

  1. Glass Prefillable Syringe Solution Delivering Complex Biologics 5/9/2022

    BD Neopak™ XtraFlow™ Glass Prefillable Syringe solution leverages 8 mm needle length in combination with thin wall cannula to reduce pressure drop and enhance flow.

  2. Container Closure Integrity USP <1207> 2/4/2022

    Within the pharmaceutical industry Container Closure Integrity Testing (CCIT) is crucial in ensuring safety and efficacy for the end-user, as well as promoting maximum shelf life for the product. This quick-reference guide represents the various testing methods elaborated by USP <1207>.

  3. Pharmaceutical Development 4/24/2023

    Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

  4. Small, Simple-To-Use Package For Delivering High-Viscosity Formulations 2/10/2021

    Subcutaneous

    Low - Medium Viscosities
    < 100 cP
    1 - 10 ml

    High - Ultra-High Viscosities
    >100 - 10,000 cP
    0.5 - 3 ml

    ArQ® - Bios offers a small, simple to use package to deliver high viscosity formulations. Oval’s proprietary COC PDC technology allows us to build the device around a stronger drug container that can deliver 1ml of formulations up to 1000cP through a 25G needle in  less than 5 seconds. The ArQ-Bios  platform  also can deliver  greater volumes than 1 ml subject to matching  the formulation characteristics with acceptable patient tolerability.

  5. Formulations For Poorly Soluble And Low Bioavailability Drugs 1/28/2022

    Ascendia specializes in the development of market suitable formulations for poorly water soluble drug substances. Based on the pre-formulation data package and the delivery requirements for the product, we recommend a comprehensive formulation development strategy. We understand that each formulation is unique and must address the specific challenges associated with poor solubility, inadequate bioavailability, and/or unacceptable physical/chemical stability. We also understand the urgency companies have for progressing their pipeline, and our approach maximizes the probability of success by exploring multiple formulation options in parallel if necessary.

  6. Sterile Fill-Finish Facility: Your Integrated Partner For Customized Clinical Supplies 2/25/2022

    Syngene's Sterile Fill-Finish facility is custom-built to meet market demand for clinical supplies, sterile drug products having short development timelines,

  7. Drug Product Manufacturing: Aseptic Fill Finish

    Ajinomoto Bio-Pharma Services offers the capacity and quality to scale your process through clinical development and commercialization.

  8. Patient-Centric Drug Delivery Device 2/10/2021

    Subcutaneous
    Low - Medium Viscosities
    < 100 cP
    0.5 - 3 ml

    ArQ® is built around our cyclic olefin copolymer (COC) primary drug container. It offers an autoinjector that is simple to use for the patient, with the flexibility and ability to deliver a wide range of viscosities and volumes.

  9. Aidaptus® Manufacturing

    We are the exclusive manufacturing partner for this innovative auto-injector platform.

  10. Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.